```html

Renal Failure (Acute Kidney Injury) – A Comprehensive Medical Guide

Overview

Acute kidney injury (AKI), historically called acute renal failure, is a sudden decline in kidney function that develops over hours to days. The kidneys lose the ability to filter waste products, balance fluids, and regulate electrolytes. AKI can affect anyone, but it is most common in hospitalized patients, especially those in intensive‑care units (ICUs).

• Incidence: Approximately 1–2 % of all hospital admissions develop AKI, and up to 30 % of ICU patients are affected.<sup>CDC</sup>
• Age distribution: Incidence rises sharply after age 65; older adults account for ~60 % of cases.<sup>Mayo Clinic</sup>
• Gender: Slight male predominance (≈55 % male).

When kidney function improves within a few weeks, the condition is termed “reversible” AKI. In some patients, especially those with pre‑existing chronic kidney disease (CKD), AKI may lead to permanent loss of function.

Symptoms

Symptoms can be subtle or absent in the early stages. Recognizing the full spectrum is essential for prompt evaluation.

General signs

• Decreased urine output (oliguria): < 500 mL/day or a sudden drop in volume.
• Anuria: < 100 mL/day; a medical emergency.
• Swelling (edema): Usually in the legs, ankles, or around the eyes due to fluid retention.
• Fatigue or weakness: Resulting from anemia or buildup of toxins.
• Nausea, vomiting, loss of appetite: Consequence of uremia.

Specific systemic clues

• Shortness of breath: Fluid accumulation in the lungs (pulmonary edema).
• Chest pain or pressure: May indicate fluid overload or electrolyte disturbance (e.g., hyperkalemia).
• Confusion or decreased mental alertness: Uremic encephalopathy.
• Metallic taste or bad breath (uremic frost): Accumulated waste products.
• Hypertension or, paradoxically, low blood pressure: Reflects volume status and renin‑angiotensin system activation.

Causes and Risk Factors

AKI results from one or more of three broad mechanisms: pre‑renal (impaired blood flow), intrinsic renal (damage to kidney tissue), and post‑renal (obstruction of urine outflow). Most cases involve a combination of factors.

Pre‑renal causes

• Severe dehydration (vomiting, diarrhea, burns).
• Hypotension from sepsis, heart failure, or major surgery.
• Medications that reduce renal perfusion (e.g., ACE inhibitors, NSAIDs, diuretics) in susceptible patients.

Intrinsic renal causes

• Acute tubular necrosis (ATN): Most common intrinsic cause; often due to ischemia or nephrotoxic drugs (contrast media, aminoglycosides, amphotericin B).
• Glomerulonephritis: Autoimmune diseases (lupus, ANCA‑associated vasculitis).
• Acute interstitial nephritis: Allergic reaction to drugs (penicillins, PPIs, NSAIDs).
• Rhabdomyolysis: Muscle breakdown releasing myoglobin, which obstructs tubules.
• Hemolytic uremic syndrome: Often triggered by certain bacterial infections.

Post‑renal causes

• Urinary tract obstruction (kidney stones, enlarged prostate, strictures).
• Catheter blockage or malfunction.

Key risk factors

• Advanced age (>65 years)
• Pre‑existing CKD or dialysis dependence
• Diabetes mellitus
• Heart failure or liver cirrhosis
• Recent major surgery or trauma
• Exposure to nephrotoxic agents (contrast dye, certain antibiotics, chemotherapy)
• Sepsis or severe infections

Diagnosis

Diagnosis hinges on rapid identification of a decline in kidney function, coupled with an investigation into the underlying cause.

Laboratory tests

• Serum creatinine: A rise of ≥0.3 mg/dL within 48 h or 1.5–1.9× baseline within 7 days meets KDIGO AKI criteria.<sup>KDIGO</sup>
• Blood urea nitrogen (BUN): Often rises in parallel with creatinine; BUN/creatinine ratio helps differentiate pre‑renal vs. intrinsic causes.
• Electrolytes: Hyperkalemia, metabolic acidosis, and phosphate elevation are common.
• Complete blood count: Detects anemia, leukocytosis (infection), or hemolysis.
• Urinalysis: Looks for casts (muddy brown granular casts suggest ATN), protein, hematuria, or eosinophils (interstitial nephritis).
• Serum biomarkers (research): Neutrophil gelatinase‑associated lipocalin (NGAL) and kidney injury molecule‑1 (KIM‑1) may aid early detection but are not yet routine.

Imaging

• Renal ultrasound: First‑line to rule out obstruction, assess kidney size and blood flow.
• CT scan with contrast: Used cautiously; contrast itself can cause AKI, so pre‑hydration protocols are mandatory.

Other investigations

• Kidney biopsy: Reserved for unexplained AKI when glomerular disease is suspected.
• Fractional excretion of sodium (FeNa): Helps differentiate pre‑renal (<1 %) from intrinsic (>2 %) injury.

Treatment Options

The cornerstone of AKI management is rapid identification and reversal of the precipitating cause, while supporting kidney function and preventing complications.

Immediate measures

• Discontinue or adjust dosage of nephrotoxic drugs.
• Optimize hemodynamics – ensure adequate intravascular volume (often isotonic saline) or, if volume‑overloaded, use diuretics cautiously.
• Address sepsis with timely antibiotics and source control.
• Relieve urinary obstruction (catheter placement, urologic surgery).

Medications

• Diuretics (e.g., furosemide): Used for fluid overload; do not improve GFR but help manage volume.
• Vasopressors (norepinephrine, phenylephrine): For hypotensive patients to maintain renal perfusion pressure.
• Renin‑angiotensin‑system blockers: Usually held during acute injury; may be re‑introduced once kidney function stabilizes.
• Sodium bicarbonate: Considered in severe metabolic acidosis (pH < 7.1) or when large amounts of myoglobin/rhabdomyolysis are present.

Renal replacement therapy (RRT)

Indicated when AKI is severe or life‑threatening.

• Intermittent hemodialysis: Conventional thrice‑weekly schedule.
• Continuous renal replacement therapy (CRRT): Preferred in hemodynamically unstable ICU patients.
• Decision to start RRT is based on “AEIOU” criteria: Acidosis, Electrolyte imbalance, Fluid overload, Intoxication, and Uremic complications.

Lifestyle & supportive care

• Strict fluid balance monitoring (intake vs. output).
• Low‑potassium, low‑phosphate diet while kidneys recover.
• Nutrition support with adequate protein (0.6–0.8 g/kg/day) to avoid catabolism.
• Physical activity as tolerated to preserve muscle mass.

Living with Renal Failure (Acute Kidney Injury)

Even after discharge, many patients experience lingering symptoms and must adopt strategies to protect recovering kidneys.

Daily management tips

• Track urine output: Document volume, color, and any changes. Report sudden drops to a healthcare provider.
• Fluid guidance: Follow the fluid limits set by your nephrologist; excessive intake can worsen edema.
• Medication safety: Keep an up‑to‑date list. Avoid over‑the‑counter NSAIDs, certain herbal supplements, and contrast studies unless absolutely necessary.
• Dietary considerations:
  • Limit high‑potassium foods (bananas, oranges, tomatoes) if labs are elevated.
  • Reduce sodium (< 2 g/day) to control blood pressure and fluid retention.
  • Stay within protein recommendations; a renal dietitian can personalize goals.
• Blood pressure monitoring: Aim for < 130/80 mmHg unless otherwise instructed; uncontrolled hypertension accelerates kidney injury.
• Follow‑up labs: Regular serum creatinine, electrolytes, and urine studies as ordered—usually weekly during recovery.
• Vaccinations: Influenza, COVID‑19, pneumococcal vaccines are recommended to reduce infection risk that can precipitate AKI.<sup>CDC</sup>

Emotional & psychosocial support

AKI can be frightening, especially after a hospital stay. Consider counseling, support groups, or kidney‑specific NGOs such as the National Kidney Foundation.

Prevention

Because many AKI episodes are avoidable, proactive measures are vital.

• Hydration: Maintain adequate fluid intake, especially during illness, hot weather, or when taking medications that increase renal workload.
• Medication review: Before starting new drugs, discuss kidney safety with your doctor or pharmacist.
• Contrast protection: When imaging with iodinated contrast is required, receive pre‑hydration (e.g., 1 L isotonic saline) and use low‑osmolar agents.
• Control chronic diseases: Tight glycemic control in diabetes, blood pressure control in hypertension, and lipid management reduce AKI risk.
• Avoid nephrotoxins: Limit NSAIDs, avoid illicit drug use, and be cautious with herbal supplements.
• Early infection treatment: Prompt antibiotics for urinary or systemic infections prevent sepsis‑related kidney injury.
• Monitor at‑risk patients: Hospital protocols for high‑risk groups (e.g., heart failure, post‑surgery) that include daily creatinine checks.

Complications

If AKI is not promptly treated, a cascade of serious complications may develop.

• Fluid overload: Leading cause of pulmonary edema, respiratory failure, and need for mechanical ventilation.
• Electrolyte disturbances: Hyperkalemia can cause life‑threatening cardiac arrhythmias.
• Metabolic acidosis: Impairs cardiac contractility and can precipitate shock.
• Uremia: Presents with pericarditis, encephalopathy, platelet dysfunction, and bleeding.
• Chronic kidney disease: AKI is an independent risk factor for progression to CKD and end‑stage renal disease (ESRD). Studies show up to 20 % of patients with severe AKI develop CKD within 5 years.<sup>NEJM</sup>
• Increased mortality: In ICU settings, mortality rates range from 30–60 % depending on severity and comorbidities.<sup>CDC</sup>

When to Seek Emergency Care

Early emergency care can prevent irreversible kidney damage and improve survival.

---

References: Mayo Clinic, CDC, KDIGO Clinical Practice Guidelines, National Kidney Foundation, Cleveland Clinic, NEJM, WHO.

```